Roche wins Midlands LIMS contract

  • 14 August 2012

The Coventry and Warwickshire Pathology Services Network, which involves three Midlands acute trusts, has awarded its laboratory information management system contract to Roche Diagnostics, in a deal that could be worth around £7m.

The network was established in May 2008 and provides cellular pathology, microbiology and blood sciences to George Eliot Hospital NHS Trust, South Warwickshire NHS Foundation Trust, University Hospitals Coventry and Warwickshire NHS Trust, and surrounding primary care services.

The tendering process was led by University Hospitals Coventry and Warwickshire, which hosts the service that provides specific services such as clinical biochemistry, immunology, molecular biology, blood transfusion and phlebotomy.

Roche Diagnostics will be expected to supply the software, hardware and interfaces for the system as well as providing training, implementation and ongoing support for the system during the ten-year contract.

The award notice states that pathology services are being encouraged to “form networks” and there is potential for the Coventry and Warwickshire Pathology Services Network “to form a cluster and join with other pathology services locally in the future.”

This means the LIMS services contract might be extended to form part of an Central and East cluster.

The contract has been valued between £2.36m and £6.989m, dependent on the number of other pathology services that decide to join.

 

Subscribe to our newsletter

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Sign up

Related News

Digital Health Coffee Time Briefing ☕

Digital Health Coffee Time Briefing ☕

This briefing features North West Anglia NHS FT replacing two LIMS with Clinisys Winpath and Asda offering online pharmacy home delivery.
NHS Scotland Boards go live with Magentus LIMS

NHS Scotland Boards go live with Magentus LIMS

Three NHS Scotland Boards have gone live with the Evolution vLab LIMS system by Magentus, connecting laboratory medicine services across multiple sites
UK govt invests £10m in tech to destroy cancers and predict disease

UK govt invests £10m in tech to destroy cancers and predict disease

The UK government has made a multi-million pound government investment in potential breakthrough medical devices.